What studies show: In the SELECT trial , people using semaglutide for type 2 diabetes experienced an average weight loss of 10.2% at 208 weeks, compared with 1.5% with a placebo
We evaluated Knoxville's GLP-1 providers and ranked the top 10 based on patient ratings, verified reviews, provider credentials, pricing transparency, and telehealth availability
Risks such as infection, allergic reactions, or improper administration must be considered
"Everyone qualifies" or approval without a real medical intake is the biggest red flag legitimate GLP-1 prescribing requires BMI documentation, contraindication screening (MTC/MEN2 history, pancreatitis, severe gastroparesis, pregnancy), and medication review
You should also talk to your doctor for advice